Hims vs Marek Health: Which TRT Provider Is Actually Right for You?

Hims and Marek Health both sell access to a physician who can prescribe testosterone therapy, but that's about where the similarity ends. Hims is the DTC playbook applied to hormone health — fast intake, bundled pricing, a slick app, and a name you already know from hair loss and ED ads. Marek Health is the opposite instinct: a concierge-style clinic built by people who think most TRT providers are checking one box on a form when they should be checking twenty.

The quick answer: Hims is the better fit if you want the cheapest, fastest path to a prescription and your case is straightforward — mild-to-moderate symptoms, no complicating factors, and a preference for convenience over depth. Marek Health is the better fit if you want a physician who's actually looking at 130+ biomarkers, not just testosterone and SHBG, and you're willing to pay two to three times more for that depth. Below, we break down exactly what that price difference buys you.

Side-by-Side Comparison Table

Key Differences Breakdown

1. Price and What It Actually Buys

Hims markets itself around a low headline number — plans run from $99/month (10-month prepay) up to $195/month, and that covers labs, a provider consultation, and medication in one bundle. Marek Health doesn't bundle anything. You pay a $250 onboarding deposit, then buy lab panels ($250-$850 depending on depth), provider consultations ($250 each), and medication ($100-$150/month) separately. Once you add it up, a typical Marek patient pursuing TRT spends $3,300-$3,900 a year, versus roughly $2,340 a year for Hims' standard plan. Hims wins on raw cost by a wide margin — Marek costs somewhere between 40% and 65% more depending on how many lab panels you order.

2. Bloodwork Depth

This is where the two companies stop looking like they're selling the same thing. Hims tests the essentials: total and free testosterone, SHBG, LH, FSH, estradiol, a CBC, and a metabolic panel — enough to diagnose straightforward low testosterone. Marek's Comprehensive and Complete panels run 100-130+ biomarkers, adding thyroid function tests (TSH, Free T3, Free T4, reverse T3), inflammatory markers (hsCRP, homocysteine), lipid subfractions, ApoB, and full micronutrient screening. If your symptoms have more than one cause — say, low T plus a sluggish thyroid plus insulin resistance — Hims' panel won't catch that. Marek's will. Marek wins decisively on diagnostic depth.

3. Medication Menu

Hims has narrowed its focus to three tiers: enclomiphene (a SERM that stimulates your own testosterone production and preserves fertility), Kyzatrex (FDA-approved oral testosterone), and injectable testosterone, which is still rolling out state by state. Marek offers all of that plus peptide therapy (BPC-157 for tissue repair), GLP-1 agonists for metabolic optimization, and a proprietary compounded hair loss topical, with access to 500+ therapies total depending on what your bloodwork indicates. Marek wins for anyone whose needs might extend beyond a single hormone.

4. Physician Interaction

Hims runs primarily on asynchronous review — you fill out an intake form, your labs come back, and a provider messages you a treatment plan. It's fast, but it's not a conversation. Marek pairs you with a Patient Care Coordinator first, then a physician who reviews your panel in detail and explains why something is off, not just that it is. If you're the type of person who wants to understand the mechanism behind your protocol, not just receive one, Marek wins here too.

5. Brand Trust Signals

Hims carries broad name recognition from its hair loss and ED business, but that hasn't translated into consistently strong reviews for its testosterone arm — a 3.0 Trustpilot rating from roughly 7,000 reviews suggests a mixed patient experience. Marek, co-founded by Derek from More Plates More Dates, has built a smaller but far more enthusiastic base: a 5.0 rating from 875+ reviews. Fewer total reviews, but a much stronger signal of satisfaction among people who've actually used the service. Marek wins on patient sentiment, though Hims' larger review base gives you more data points to weigh.

6. Fertility-Preserving Options

Both platforms offer enclomiphene, the SERM that stimulates your own testosterone production instead of replacing it — a meaningful option if you want to avoid the fertility suppression that comes with exogenous testosterone. Hims markets enclomiphene as its core, default offering, which means it's front and center in the intake flow. Marek offers enclomiphene too, but as one option among a much larger menu, selected based on what your bloodwork actually supports rather than presented as the default path. Neither company handles this poorly, but Hims makes it easier to land on enclomiphene without a broader conversation about whether it's the right call for your specific hormone picture.

7. What Happens When Your Case Isn't Simple

This is where the two companies diverge most in practice. If Hims' standard panel comes back with testosterone in a gray zone, or your symptoms don't fully resolve on enclomiphene, the DTC model doesn't have an obvious next step beyond escalating to Kyzatrex or injectable testosterone. Marek's model is built for exactly this scenario — a physician reviewing 100+ biomarkers is far more likely to spot that your fatigue is partly thyroid-driven or that elevated inflammatory markers are muddying the picture. Marek wins for anyone whose first round of treatment with a budget provider didn't fully work.

Similarities

Both companies require lab-confirmed low testosterone before prescribing anything — neither will hand you a prescription off symptoms alone, which is both a legal requirement and a basic clinical safeguard. Both use licensed physicians, ship medication directly to your door, and require ongoing monitoring (repeat bloodwork) to continue treatment. Neither accepts insurance, though both work with HSA/FSA payment. And both offer enclomiphene as a fertility-preserving alternative to direct testosterone replacement, so the "TRT vs. SERM" decision isn't exclusive to either platform.

Price and Value Analysis

On sticker price alone, Hims is the clear winner — roughly $1,000-$1,500 cheaper per year than Marek. But "value" depends heavily on what you actually need. If a standard low-T diagnosis and a straightforward enclomiphene or Kyzatrex protocol is all you need, you're paying Marek's premium for depth you won't use. If your health picture is more complicated — unexplained fatigue that could be thyroid, metabolic, or hormonal, or you want peptide therapy alongside TRT — Marek's per-dollar value goes up substantially, because a $99-$195/month DTC platform simply isn't built to catch or treat those other issues.

For the full field of options beyond just these two, our best online TRT clinics guide breaks down where budget providers like TRT Nation and mid-tier options like Ro and PeterMD fit into the picture.

Who Should Buy Hims

Hims makes sense if you have mild-to-moderate low-T symptoms, your case is uncomplicated, and cost and speed matter more to you than a deep diagnostic workup. It's also a reasonable pick if you specifically want Kyzatrex — needle-free, FDA-approved oral testosterone — since Hims has an exclusive partnership with its manufacturer. Read our full Hims TRT review for the complete breakdown of their treatment tiers and pricing.

Who Should Buy Marek Health

Marek is the right call if you've already tried a standard telehealth provider and didn't get real answers, if you suspect your symptoms have more than one root cause, or if you're specifically interested in peptide therapy alongside hormone optimization. It's built for people who treat health optimization as a long-term investment rather than a one-time fix. See our full Marek Health review for the detailed cost and protocol breakdown.

The Bottom Line

For most men with a straightforward low testosterone diagnosis, Hims is the more practical choice — it's meaningfully cheaper, faster to start, and covers the fundamentals of TRT and SERM therapy competently. Marek Health is worth the premium if your case is complicated, if a previous provider missed something, or if you want the kind of granular data most primary care doctors never order. Neither is objectively "better" — they're built for different patients with different budgets and different problems.

FAQ

Which is cheaper: Hims or Marek Health? Hims, by a significant margin. Hims runs $99-$195/month all-in depending on plan length, while a typical Marek patient spends $275-$325/month once labs, consultations, and medication are added up — roughly $1,000-$1,500 more per year.

Which one tests more biomarkers? Marek Health, by a wide margin. Its panels run from 50 to 130+ biomarkers, including thyroid, inflammatory, and metabolic markers that Hims' standard 15-20 marker panel doesn't cover.

Can I start with Hims and switch to Marek later? Yes. Some patients start with a lower-cost provider like Hims to confirm they respond to treatment, then move to Marek if they want deeper diagnostic work or their symptoms don't fully resolve. You'll need updated bloodwork with the new provider either way.

Does either accept insurance? No. Both operate on a cash-pay model, though both accept HSA and FSA cards. Neither bills insurance directly for consultations, labs, or medication.

Is Marek Health worth double or triple the cost of Hims? It depends entirely on what you need. If your case is simple, no — you're paying for diagnostic depth you won't use. If you have overlapping symptoms that a basic hormone panel can't explain, the extra cost buys real clinical value most budget providers can't offer.

Do both require ongoing bloodwork to continue treatment? Yes. Testosterone therapy affects hematocrit, PSA, and lipid markers over time, so both providers require periodic follow-up labs to keep prescribing responsibly. The Endocrine Society's clinical practice guideline recommends checking hematocrit and PSA at baseline, again at 3-6 months, and annually thereafter — skipping this isn't optional at either company.

Does either company offer treatments beyond testosterone? Marek does, extensively — peptide therapy, GLP-1 agonists, thyroid management, and hair loss compounds are all part of its menu. Hims is narrower, focused mainly on testosterone-adjacent treatments (enclomiphene, Kyzatrex, and soon injectables), though it also runs separate hair loss and weight loss product lines outside of its TRT offering.

Which one is faster to get started with? Hims, generally. Its asynchronous, app-driven intake is built for speed — many users complete labs and get a treatment plan within one to two weeks. Marek's multi-step process (PCC intake, lab panel selection, physician review) typically takes a bit longer given the added coordination, though it's not a dramatically slower process.

Related Reading

• Best Online TRT Clinics 2026 — the full field of providers compared
• Hims TRT Review — our complete breakdown of Hims' testosterone tiers
• Marek Health Review — the full cost and protocol deep dive
• Hims vs Ro vs TRT Nation — how Hims stacks up against other budget-tier options
• TRT Guide: Everything You Need to Know — start here if you're new to TRT

Affiliate Disclosure: Freak Naturals may earn a commission on purchases made through links in this article. This does not affect our editorial independence — we recommend providers based on research and comparison, not commissions.